Cargando…

FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression

Resistance to 5-Fluoruracil (5-FU) has been linked to elevated expression of the main target, thymidylate synthase (TYMS), which catalyses the de novo pathway for production of deoxythymidine monophosphate. The potent oncogenic forkhead box transcription factor, FOXM1 is is regulated by E2F1 which a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varghese, Vidhya, Magnani, Luca, Harada-Shoji, Narumi, Mauri, Francesco, Szydlo, Richard M., Yao, Shang, Lam, Eric W.-F., Kenny, Laura M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365533/ https://www.ncbi.nlm.nih.gov/pubmed/30728402 http://dx.doi.org/10.1038/s41598-018-38017-0

Ejemplares similares

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Test Your Memory (TYM) and Test Your Memory for Mild Cognitive Impairment (TYM-MCI): A Review and Update Including Results of Using the TYM Test in a General Neurology Clinic and Using a Telephone Version of the TYM Test
por: Brown, Jeremy M., et al.
Publicado: (2019)

Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2017)

Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy
por: Jiang, Hong, et al.
Publicado: (2019)

LHC prawdopodobnie ruszy w tym tygodniu
Publicado: (2009)

DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients
por: Amirfallah, Arsalan, et al.
Publicado: (2018)

TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2019)

Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
por: Dong, Si-Qi, et al.
Publicado: (2021)

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
por: Yao, Shang, et al.
Publicado: (2018)

Delimiting Allelic Imbalance of TYMS by Allele-Specific Analysis
por: Balboa-Beltrán, Emilia, et al.
Publicado: (2015)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma
por: Chmielewska-Kassassir, Małgorzata, et al.
Publicado: (2023)

Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining
por: Jie, Yanghua, et al.
Publicado: (2021)

Wielki Zderzacz Hadron w prawdopodobnie ruszy w tym tygodniu
Publicado: (2009)

Wielki Zderzacz Hadron w prawdopodobnie ruszy w tym tygodniu
Publicado: (2009)

Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer
por: Junior, José da Silva Nogueira, et al.
Publicado: (2012)

New Insight into the Octamer of TYMS Stabilized by Intermolecular Cys43-Disulfide
por: Xie, Dan, et al.
Publicado: (2018)

Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1
por: Jeong, Ji Hye, et al.
Publicado: (2022)

XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer
por: He, Yanjing, et al.
Publicado: (2018)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer
por: Fu, Zhuo, et al.
Publicado: (2019)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
por: Zhang, X, et al.
Publicado: (2017)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
por: Kelemen, Linda E., et al.
Publicado: (2018)

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
por: Loganayagam, A, et al.
Publicado: (2013)

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
por: Martinez-Balibrea, E, et al.
Publicado: (2010)

Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
por: Lima, Aurea, et al.
Publicado: (2014)

Correlation between polymorphism of TYMS gene and toxicity response to treatment with 5-fluoruracil and capecitabine
por: Vitello, Stefano, et al.
Publicado: (2020)

MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription
por: Liu, Tingting, et al.
Publicado: (2019)

Test Your Memory (TYM test): diagnostic evaluation of patients with non-Alzheimer dementias
por: Brown, Jeremy, et al.
Publicado: (2019)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study
por: Yao, Li, et al.
Publicado: (2019)

MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil
por: Khalili, Elham, et al.
Publicado: (2023)

FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer
por: Yang, Yuhan, et al.
Publicado: (2020)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gcvafmkis71aiskemej8mdm3lm